Thomas Jang (@tomjanguroonc) 's Twitter Profile
Thomas Jang

@tomjanguroonc

Professor & Chief of Urologic Oncology @RutgersCancer; Urology Residency Program Director @rwjurology

ID: 938459144801210378

linkhttps://www.cinj.org/thomas-jang-md-mph-facs calendar_today06-12-2017 17:24:30

674 Tweet

1,1K Takipçi

1,1K Takip Edilen

Rutgers Cancer Institute (@rutgerscancer) 's Twitter Profile Photo

#MondaysAtTheMorris Rutgers Cancer Institute RWJBarnabas we are getting ready for the opening of the new Jack & Sheryl Morris Cancer Center! This facility will be home to state-of-the-art research labs helping bring the future of cancer care to our communities.

Vignesh Packiam, MD (@vigneshpackiam) 's Twitter Profile Photo

Just in time for AUA - A high-quality succinct review on contemporary intravesical therapy on NMIBC by the great Saum Ghodoussipour & all ⭐️ colleagues in European Urology Beautiful figures too! A valuable resource for patients & urologists Bladder Cancer Advocacy Network YUO pubmed.ncbi.nlm.nih.gov/40253283/

Just in time for AUA - A high-quality succinct review on contemporary intravesical therapy on NMIBC by the great <a href="/saumyg/">Saum Ghodoussipour</a> &amp; all ⭐️ colleagues in <a href="/EUplatinum/">European Urology</a>  

Beautiful figures too!

A valuable resource for patients &amp; urologists <a href="/BladderCancerUS/">Bladder Cancer Advocacy Network</a> <a href="/SUO_YUO/">YUO</a>

pubmed.ncbi.nlm.nih.gov/40253283/
Rutgers Cancer Institute (@rutgerscancer) 's Twitter Profile Photo

Congratulations to Dr. Saum Ghodoussipour Saum Ghodoussipour, Director of the Bladder & Urothelial Cancer Program at Rutgers Cancer Institute on receiving the 2025 SUO-CTC CG Oncology NMIBC Fellowship from the Society of Urologic Oncology Clinical Trials Consortium Society of Urologic Oncology! ir.cgoncology.com/news-releases/…

Congratulations to Dr. Saum Ghodoussipour <a href="/saumyg/">Saum Ghodoussipour</a>, Director of the Bladder &amp; Urothelial Cancer Program at <a href="/RutgersCancer/">Rutgers Cancer Institute</a> on receiving the 2025 SUO-CTC CG Oncology NMIBC Fellowship from the Society of Urologic Oncology Clinical Trials Consortium <a href="/UroOnc/">Society of Urologic Oncology</a>!

ir.cgoncology.com/news-releases/…
UroToday.com (@urotoday) 's Twitter Profile Photo

Biomarkers for gemcitabine docetaxel in non-muscle invasive #BladderCancer. Vignesh Packiam, MD Rutgers Cancer Institute joins Joep J. de Jong Erasmus MC to discuss promising results for non-muscle invasive bladder cancer, with potential biomarkers on the horizon for precision medicine. #WatchNow

Biomarkers for gemcitabine docetaxel in non-muscle invasive #BladderCancer. <a href="/VigneshPackiam/">Vignesh Packiam, MD</a> <a href="/RutgersCancer/">Rutgers Cancer Institute</a> joins <a href="/JoepJdeJong/">Joep J. de Jong</a> <a href="/ErasmusMC/">Erasmus MC</a> to discuss promising results for non-muscle invasive bladder cancer, with potential biomarkers on the horizon for precision medicine. #WatchNow